SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-233448
Filing Date
2023-09-12
Accepted
2023-09-12 16:05:57
Documents
28
Period of Report
2023-09-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d550960d8k.htm   iXBRL 8-K 115753
2 EX-3.1 d550960dex31.htm EX-3.1 25995
3 EX-4.1 d550960dex41.htm EX-4.1 70946
4 EX-4.2 d550960dex42.htm EX-4.2 156265
5 EX-10.1 d550960dex101.htm EX-10.1 100981
6 EX-10.2 d550960dex102.htm EX-10.2 61388
7 EX-10.3 d550960dex103.htm EX-10.3 58748
8 EX-10.4 d550960dex104.htm EX-10.4 76888
9 EX-10.5 d550960dex105.htm EX-10.5 24368
10 EX-10.6 d550960dex106.htm EX-10.6 24827
11 EX-14.1 d550960dex141.htm EX-14.1 60310
12 EX-16.1 d550960dex161.htm EX-16.1 2251
13 EX-99.1 d550960dex991.htm EX-99.1 4104
14 EX-10.7 d550960dex107.htm EX-10.7 24648
19 GRAPHIC g550960dsp130.jpg GRAPHIC 11831
20 GRAPHIC g550960dsp40.jpg GRAPHIC 17735
  Complete submission text file 0001193125-23-233448.txt   1233788

Data Files

Seq Description Document Type Size
15 XBRL TAXONOMY EXTENSION SCHEMA dnth-20230911.xsd EX-101.SCH 3229
16 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dnth-20230911_def.xml EX-101.DEF 14633
17 XBRL TAXONOMY EXTENSION LABEL LINKBASE dnth-20230911_lab.xml EX-101.LAB 24258
18 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dnth-20230911_pre.xml EX-101.PRE 15569
22 EXTRACTED XBRL INSTANCE DOCUMENT d550960d8k_htm.xml XML 5404
Mailing Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139
Business Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Dianthus Therapeutics, Inc. /DE/ (Filer) CIK: 0001690585 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38541 | Film No.: 231250134
SIC: 2834 Pharmaceutical Preparations